AC: Key Enzyme in Adenosine Regulation (P9245)

Target Name: Adenylate Cyclase

NCBI ID: P9245

Adenylate Cyclase

Other Name(s): AC

AC: Key Enzyme in Adenosine Regulation

Adenylate Cyclase (AC) is a protein that is involved in the regulation of the body's cellular processes. It is a key enzyme in the cycle of adenosine, which is a molecule that plays a crucial role in many different cellular processes. In this article, we will discuss AC and its potential as a drug target or biomarker.

AC is a protein that is found in most cells of the body. It is made up of 26 different amino acids and has a molecular weight of 43 kDa. AC is primarily localized to the endoplasmic reticulum, which is the membrane-bound organelle that retrieves and modifies proteins before they are released into the cytoplasm.

One of the key functions of AC is to regulate the levels of adenosine in the body. Adenosine is a naturally occurring molecule that is involved in many different cellular processes, including signaling, messaging, and regulation of ion channels. It is produced by the body's cells in response to various stimuli, such as exercise, stress, or infection.

AC is involved in the regulation of adenosine levels by activating the enzyme adenylate cyclase (AC). This enzyme is responsible for converting the amino acid adenylate to the more potent molecule cyclic adenosine monophosphate (cAMP). cAMP is then used to regulate a wide range of cellular processes, including muscle contractions, blood pressure, and cell signaling.

In addition to its role in regulating adenosine levels, AC is also involved in the regulation of many other cellular processes. For example, it is involved in the regulation of protein synthesis and in the detoxification of harmful substances. It is also involved in the regulation of cell death, and has been shown to play a role in the development of certain diseases, such as heart disease and cancer.

As a drug target, AC has the potential to be used to treat a wide range of diseases. For example, because AC is involved in the regulation of many cellular processes, it could be used to treat a variety of conditions that are caused by changes in these processes, such as heart disease, cancer, and neurological disorders. In addition, because AC is involved in the regulation of adenosine levels, it could be used to treat conditions that are characterized by high levels of adenosine, such as insomnia and anxiety.

As a biomarker, AC has the potential to be used as a diagnostic tool for a wide range of diseases. For example, because AC is involved in the regulation of many cellular processes, it could be used to predict the outcome of certain diseases, such as heart disease and cancer. In addition, because AC is involved in the regulation of adenosine levels, it could be used to predict the response of certain diseases to certain treatments.

In conclusion, Adenylate Cyclase (AC) is a protein that is involved in the regulation of many different cellular processes in the body. It has the potential to be a drug target or biomarker, and is being studied for its potential to treat a wide range of diseases. Further research is needed to fully understand the role of AC and its potential as a drug or biomarker.

Protein Name: Adenylate Cyclase (nonspecified Subtype)

The "Adenylate Cyclase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Adenylate Cyclase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets